Irinotecan-induced dysarthria

MeSH terms

• Adenocarcinoma / drug therapy
• Adenocarcinoma / secondary
• Adult
• Antineoplastic Agents, Phytogenic / administration & dosage
• Antineoplastic Agents, Phytogenic / adverse effects*
• Antineoplastic Agents, Phytogenic / cerebrospinal fluid
• Antineoplastic Agents, Phytogenic / pharmacokinetics
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Aphasia, Broca / chemically induced
• Bone Neoplasms / drug therapy
• Bone Neoplasms / secondary
• Camptothecin / administration & dosage
• Camptothecin / adverse effects*
• Camptothecin / analogs & derivatives*
• Camptothecin / cerebrospinal fluid
• Camptothecin / pharmacokinetics
• Dysarthria / chemically induced*
• Enzyme Inhibitors / administration & dosage
• Enzyme Inhibitors / adverse effects*
• Enzyme Inhibitors / cerebrospinal fluid
• Enzyme Inhibitors / pharmacokinetics
• Fatal Outcome
• Female
• Fluorouracil / administration & dosage
• Humans
• Infusions, Intravenous
• Irinotecan
• Lung Neoplasms / drug therapy
• Lung Neoplasms / secondary
• Magnetic Resonance Imaging
• Organoplatinum Compounds / administration & dosage
• Oxaliplatin
• Premedication
• Sigmoid Neoplasms / drug therapy